Fluzone (influenza vaccine) is safe to receive while pregnant or breastfeeding. Certain factors, including the risks of not receiving the vaccine during pregnancy, may determine whether you should ...

Fluzone High-Dose was 24.2% more effective in preventing influenza in adults aged 65 years or older than regular Fluzone in a large-scale clinical trial, vaccine maker Sanofi Pasteur told the Advisory ...

The US Food and Drug Administration (FDA) has approved Fluzone (Sanofi) high-dose quadrivalent influenza vaccine for adults aged 65 years and older. This approval is the final step toward the ...

The FDA has approved the supplemental Biologics License Application (sBLA) for Fluzone High-Dose Quadrivalent (Influenza Vaccine; Sanofi Pasteur) for active immunization for the prevention of ...

PARIS - November 4, 2019 – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in ...

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license ...

The approval was based on findings from a Phase 4 safety and immunogenicity study that included ~2000 children. The Food and Drug Administration (FDA) has approved the expanded use of Fluzone ...

Not all flu shots are created equal. That's the message Sanofi wants to convey as it pushes the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) to ...

Fluzone High-Dose is a vaccine. This vaccine is recommended to help protect against influenza (flu) and associated pneumonia in persons aged 60 years and older. For more information, see Section 1.

Please provide your email address to receive an email when new articles are posted on . The FDA approved a supplemental Biologic License Application for the Fluzone High-Dose Quadrivalent vaccine for ...

PARIS, Nov. 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for ...